O-2545

From Wikipedia, the free encyclopedia
Jump to: navigation, search
O-2545
O-2545.svg
Systematic (IUPAC) name
(6aR,10aR)-6a,7,10,10a-Tetrahydro-3-[5-(1H-imidazol-1-yl)-1,1-dimethylpentyl]-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
Legal status
Legal status
  • Unscheduled
Identifiers
CAS Number 874745-42-3 YesY
ChemSpider 22938186 N
Chemical data
Formula C26H36N2O2
Molar mass 408.575 g/mol
 NYesY (what is this?)  (verify)

O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water-soluble, which gives it considerable advantages over many related cannabinoids. It has high affinity for both CB1 and CB2 receptors, with Ki values of 1.5 nM at CB1 and 0.32 nM at CB2.[1]


See also[edit]

References[edit]

  1. ^ Martin BR, et al. Pharmacological characterization of novel water-soluble cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 2006 Sep;318(3):1230-9. PMID 16757541